Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit (C2) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 10 - 14, 2019 at Whistler Conference Centre, Whistler, British Columbia, Canada.
Course Description :
Cancer immunotherapy is now an established field that has led to remarkable clinical benefit for a subset of patients. However, a deeper understanding of the mechanisms of response and resistance to current immunotherapy strategies is needed to help develop new treatments that will improve the number of patients who will benefit. This meeting will explore mechanisms related to response and resistance, including novel methodologies to identify these mechanisms, and provide insights into new targets and combinatorial therapies that are being developed.
Additional details will be posted as soon as they are available.